Application Scenarios
This product is primarily intended for individuals who require robust weight management but have shown an inadequate response to single-pathway GLP-1 medications or have reached a weight-loss plateau prematurely. In the context of bodybuilding and physique management, it is suitable for:
Advanced trainees who need to break through a weight or body-fat plateau during a cutting phase;
Individuals who experience a decline in satiety or a significant resurgence in appetite after using a GLP-1 monotherapy;
Those preparing for competitions or physique-focused goals who wish to minimize the loss of lean body mass while shedding fat (requires concurrent resistance training and a high-protein diet).
Physical Mechanism
Cagrilintide acts as a dual agonist for the amylin receptor (AMYR) and the calcitonin receptor (CTR). Its primary target is the area postrema in the brainstem; by activating the AMY1R and AMY3R subtypes, it transmits satiety signals downstream to the nucleus of the solitary tract and the parabrachial nucleus, thereby suppressing food intake. Structural biology studies indicate that the F23 residue of Cagrilintide anchors into the receptor's transmembrane domain, while an intramolecular salt bridge between E14 and R17 enhances helical stability, allowing the molecule to activate the receptor efficiently via an "alternative" (bypass) mode.
Semaglutide, meanwhile, acts on the hypothalamus and brainstem via the GLP-1 receptor, delaying gastric emptying and enhancing post-meal satiety. The synergy between these two pathways at the central nervous system level results in an appetite-suppressing effect that is multiplicative-or at least greater than the simple sum of the individual effects.
Benefits in Bodybuilding
The core value lies in its potential to facilitate fat loss while preserving lean muscle mass. During weight loss driven solely by caloric restriction or GLP-1 monotherapy, the loss of lean body mass often accounts for 25–40% of the total weight lost. Preclinical research suggests that the amylin pathway, targeted by Cagrilintide, may help preserve lean body mass. For bodybuilders, this implies a potentially lower risk of muscle loss while maintaining the same caloric deficit. Furthermore, the delay in gastric emptying caused by Cagrilintide extends the window of amino acid availability following a meal. When combined with a strategy of distributing protein intake across multiple meals, this may create a more favorable environment for muscle protein synthesis. It must be emphasized, however, that the drug itself does not build muscle; its value lies solely in making the caloric deficit during a fat-loss phase easier to maintain and more sustainable.
Dietary and Medication Considerations
Dietary: Due to significantly delayed gastric emptying, avoid consuming large-volume meals or meals high in fat or fiber at one time, as this can easily lead to bloating and nausea. It is recommended to eat smaller, more frequent meals, prioritizing protein intake-aiming for at least 1.6 g/kg of body weight daily to counteract the loss of lean body mass. Ensure adequate hydration (approximately 2.5 L/day for men), as dehydration resulting from vomiting or diarrhea is the primary reason for discontinuing treatment.
Medication: Common adverse effects include gastrointestinal issues (nausea, vomiting, diarrhea), which typically occur during the dose-escalation phase and tend to subside with continued use. Do not consume alcohol or high-sugar beverages, as these can exacerbate gastric discomfort. If you experience persistent, severe upper abdominal pain, discontinue use immediately and have your lipase levels checked (to screen for pancreatitis). When stopping the medication, taper the dosage gradually rather than stopping abruptly to minimize the risk of a rebound in appetite.
Why Choose Us
We are the primary manufacturer. Our entire production process-from peptide synthesis to purification and lyophilization-is handled in-house, with no intermediaries. Equipped with industrial-grade preparative HPLC and mass spectrometry systems, every batch undergoes rigorous purity verification and structural confirmation to ensure the sequence integrity and correct modification sites for both Cagrilintide and Semaglutide. We offer stable supply, consistent quality across batches, and dedicated technical support. We do not sell "concepts"-we deliver compounds that stand up to rigorous testing.
FAQ:
Q: Where are your products manufactured?
A: Our products are manufactured in Shenzhen, China.
Q: What is the minimum order quantity (MOQ)?
A: The minimum order quantity is 10 vials/units. Q: How soon will my order be shipped?
A: Orders for in-stock items are dispatched within 24 hours.
Q: What purity levels do you offer?
A: Our standard purity is 99%.
Q: Which shipping carriers do you use?
A: We offer shipping via FedEx, DHL, UPS, and postal services.
Q: How long does shipping take?
A: Approximately 10–15 days.
Q: Can you provide a COA (Certificate of Analysis) and an HPLC (High-Performance Liquid Chromatography) test report?
A: Yes, these are available. All products undergo professional testing before shipment.
Q: Do you offer OEM/private labeling services?
A: Yes, OEM/private labeling services are available, subject to a minimum order quantity (MOQ).
Q: How do you handle after-sales issues?
A: If a quality issue attributable to our production is confirmed after you receive the goods, we offer free replacement or a refund. We are committed to a pragmatic and responsible service approach; we address all concerns proactively and appropriately-never evading responsibility-to fully protect our customers' interests.
Q: What payment methods do you accept?
A: We accept bank transfers, Bitcoin, TransferWise, and Xoom.
Hot Tags: cagrilintide 5mg + semaglutide 5mg for appetite control during the pre-competition phase, China cagrilintide 5mg + semaglutide 5mg for appetite control during the pre-competition phase manufacturers, suppliers, factory
